271 related articles for article (PubMed ID: 23797978)
1. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
2. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
4. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
5. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
6. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
7. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
8. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
10. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
[TBL] [Abstract][Full Text] [Related]
11. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
12. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
13. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
14. Season of birth and risk of Hodgkin and non-Hodgkin lymphoma.
Crump C; Sundquist J; Sieh W; Winkleby MA; Sundquist K
Int J Cancer; 2014 Dec; 135(11):2735-9. PubMed ID: 24752499
[TBL] [Abstract][Full Text] [Related]
15. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
16. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
Chang ET; Lau EC; Mowat FS; Teta MJ
Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Profile of Hodgkin and Non-Hodgkin Lymphoma.
Shahid R; Gulzar R; Avesi L; Hassan S; Danish F; Mirza T
J Coll Physicians Surg Pak; 2016 Feb; 26(2):103-7. PubMed ID: 26876395
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation does not increase the risk of infection-related complications for pediatric patients with Hodgkin and non-Hodgkin lymphomas: A multicenter nationwide study.
Zając-Spychała O; Wachowiak J; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Więcek P; Szmydki-Baran A; Hutnik Ł; Matysiak M; Małas Z; Badowska W; Gryniewicz-Kwiatkowska O; Gietka A; Dembowska-Bagińska B; Semczuk K; Dzierżanowska-Fangrat K; Bartnik M; Ociepa T; Urasiński T; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Chybicka A; Irga-Jaworska N; Bień E; Drożyńska E; Chełmecka-Wiktorczyk L; Balwierz W; Zak I; Pierlejewski F; Młynarski W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Płonowski M; Krawczuk-Rybak M; Musiał J; Chaber R; Gamrot-Pyka Z; Woszczyk M; Tomaszewska R; Szczepański T; Kowalczyk J; Styczyński J
Transpl Infect Dis; 2020 Aug; 22(4):e13292. PubMed ID: 32285579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
